JRKL-AS1

Across TCGA pan-cancer cohorts, JRKL-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated JRKL-AS1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher JRKL-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated JRKL-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and SARC show a favorable association.

LUAD, BLCA, and BRCA are the cancer types where JRKL-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.343	0.778	.001	42	view →
BLCA	DFS	Tertile	All	0.813	0.418	.001	36	view →
BRCA	DFS	Tertile	III,IV	0.674	0.807	.014	33	view →
HNSC	OS	Tertile	IV	0.282	0.536	.023	27	view →
KIRP	OS	Tertile	II,III,IV	0.607	0.879	.012	24	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
CESC	OS	Tertile	All	0.654	0.811	.021	18	view →
LGG	DFS	Tertile	All	0.642	0.754	.028	12	view →
COAD	DFS	Tertile	IV	0.211	0.509	.007	9	view →
SARC	OS	Tertile	All	1.000	0.703	.021	9	view →
ACC	DFS	Tertile	III,IV	0.057	0.457	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

JRKL-AS1–LUAD (DFS)

Open the LUAD breakdown →